Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$225.07 - $246.17 $2.05 Million - $2.24 Million
-9,100 Reduced 72.22%
3,500 $817,000
Q1 2024

May 15, 2024

BUY
$233.45 - $247.73 $583,625 - $619,325
2,500 Added 24.75%
12,600 $3.12 Million
Q4 2023

Feb 14, 2024

BUY
$232.24 - $267.23 $2.35 Million - $2.7 Million
10,100 New
10,100 $2.46 Million
Q1 2023

May 15, 2023

SELL
$229.71 - $259.35 $1.03 Million - $1.17 Million
-4,500 Reduced 19.4%
18,700 $4.63 Million
Q4 2022

Feb 14, 2023

BUY
$218.29 - $256.91 $5.06 Million - $5.96 Million
23,200 New
23,200 $5.9 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.7B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.